ASML vs CGEM · P/E 57, $665.37B cap vs $830.3M cap
ASML Holding NV ADR (ASML) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the ASML and CGEM stock pages for the full models.
Not investment advice.